# Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization

> **NCT00930189** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Asociación para Evitar la Ceguera en México**

## Conditions studied

- Subfoveal Choroidal Neovascularization

## Interventions

- **DRUG:** intravitreal injection of ranibizumab
- **DRUG:** intravitreal injection of triamcinolone
- **PROCEDURE:** photodynamic therapy

## Key facts

- **NCT ID:** NCT00930189
- **Lead sponsor:** Asociación para Evitar la Ceguera en México
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-04
- **Primary completion:** 2006-04
- **Final completion:** 2006-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Undefined
- **Last updated:** 2024-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00930189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00930189, "Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00930189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*